[Form 4] Exzeo Group, Inc. Insider Trading Activity
Exzeo Group, Inc. reported insider trading activity by its General Counsel on 12/18/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Exzeo Group, Inc. reported insider trading activity by its General Counsel on 12/18/2025. The officer sold 3,896 shares of common stock at $19.58 per share to cover tax withholding tied to restricted stock unit vesting, and purchased 10,020 shares at the same price. Following these transactions, the officer directly owned 248,026 shares of common stock and indirectly held 1,000 shares through a spouse.
The filing also shows a stock option with the right to buy 100,000 shares of common stock at an exercise price of $23 per share, expiring on 10/01/2031. This option was originally granted on October 1, 2021 for 5,000,000 shares, with vesting beginning in 2022 and continuing in scheduled installments.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 3,896 | $19.58 | $76K |
| Purchase | Common Stock | 10,020 | $19.58 | $196K |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. The disposal reported on this Form 4 represents shares sold by the Reporting Person to cover tax witholding obligations in connection with the vesting and settlement of RSUs.
- F2. On October 1, 2021, the reporting person was granted an option to purchase 5,000,000 shares of common stock. The option vested with respect to one fourth of the shares on October 1, 2022 and with respect to one sixteenth of the shares on each January 1, April 1, July 1 and October 1 thereafter.
AI-generated analysis. How Rhea-AI works. Not financial advice.